A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients-Reference-Cited by-同舟云学术

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients

Published:2019-09-12 Issue:1 Volume:44 Page:98-110
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Lau Hubert D.,Chan Emily,Fan Alice C.,Kunder Christian A.,Williamson Sean R.,Zhou Ming,Idrees Muhammad T.,Maclean Fiona M.,Gill Anthony J.,Kao Chia-Sui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference39 articles.

1. New and emerging renal entities: a perspective post-WHO 2016 classification;Trpkov;Histopathology,2019

2. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer;Grubb;J Urol,2007

3. Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma;Ohe;Am J Surg Pathol,2018

4. Recognizing hereditary renal cancers through the microscope: a pathology update;Peng;Surg Pathol Clin,2018

5. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment;Menko;Fam Cancer,2014

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma;Modern Pathology;2024-09

2. Classification OMS 2022 des cancers du rein : focus sur le carcinome rénal papillaire;Annales de Pathologie;2024-09

3. Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians;Journal of Urologic Oncology;2024-07-31

4. A new missense mutation c.1240A>G in fumarate hydratase gene leads to uterine leiomyoma associated hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in Chinese;Translational Oncology;2024-07

5. The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management Implications;Urologic Oncology: Seminars and Original Investigations;2024-07